Lv3
328 积分 2025-12-03 加入
Efficacy and safety of aumolertinib/icotinib combination therapy for naive EGFR -mutant non–small-cell lung cancer patients with brain metastases: A phase I/II study
21小时前
待确认
Neoadjuvant dabrafenib and trametinib for functional organ preservation in recurrent BRAF V600E-mutated papillary thyroid cancer
3天前
已完结
局部晚期甲状腺癌安罗替尼靶向新辅助治疗的真实世界研究
3天前
已完结
患者报告结局测量工具在甲状腺癌临床领域的应用
12天前
已完结
Quality of Life in Thyroid Cancer is Similar to That of Other Cancers with Worse Survival
12天前
已完结
Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer
12天前
已完结
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
12天前
已完结
Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy
12天前
已完结
New Treatment Strategy and Future Research Direction for BRAF ‐Mutated Cancer
13天前
已完结
Systematic review and meta-analysis of the efficacy of dabrafenib and trametinib in the multi-modal treatment of anaplastic thyroid cancer
15天前
已完结
皖公网安备34019202002308
